LOPERAMIDE , Ultra-Levura 250 mg cápsulas duras, Placebo to Saccharomyces boulardii
BoWell - Sb252
Phase 3 small_molecule active
Quick answer
LOPERAMIDE , Ultra-Levura 250 mg cápsulas duras, Placebo to Saccharomyces boulardii for Non-constipated Irritable Bowel Syndrome (IBS) is a Phase 3 program (small_molecule) at Biocodex with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biocodex
- Indication
- Non-constipated Irritable Bowel Syndrome (IBS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active